Brand New! The U.S. FDA has approved Myhibbin™, the only ready-to-use mycophenolate mofetil oral suspension
We are thrilled to announce the launch of Myhibbin, the new FDA-approved liquid form of the immunosuppressant mycophenolate mofetil, expertly renamed by WANT Branding! Azurity Pharmaceuticals hired WANT to develop this innovative name, resulting in the clever fusion of “Mycophenolate”…